In Vitro Combination Therapy with Tegobuvir (GS-9190) is Highly Efficient in Curing Cells from HCV Replicon and in Delaying/Preventing the Development of Antiviral Resistance

✍ Scribed by Inge Vliegen; Jan Paeshuyse; I-hung Shih; Gerhard Pürstinger; Steven Bondy; William A. Lee; Weidong Zhong; Johan Neyts

• Book ID: 113458619
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 75 KB
• Volume: 90
• Category: Article
• ISSN: 0166-3542
• DOI: 10.1016/j.antiviral.2011.03.131